articl
summar
origin
research
field
respirolog
publish
critic
care
group
articl
subcategori
help
reader
get
rapid
overview
key
articl
thu
focu
topic
interest
acut
respiratori
distress
syndrom
ard
amount
aerat
lung
markedli
reduc
result
alveolar
collaps
flood
ryland
cowork
assess
volum
poorli
nonventil
ga
mechan
ventil
ard
patient
assum
differ
ratio
ventil
ga
volum
endexpiratori
lung
volum
measur
use
sulphur
hexafluorid
total
ga
volum
total
endexpiratori
ga
volum
independ
ventil
measur
use
comput
tomographi
repres
poorli
nonventil
ga
volum
onethird
total
ga
volum
poorli
nonventil
lung
ard
patient
posit
endexpiratori
pressur
peep
level
uneven
distribut
ventil
probabl
due
presenc
small
airway
closur
andor
obstruct
recruit
procedur
might
amelior
detect
recruit
henzler
cowork
compar
commonli
use
measur
lung
mechan
improv
oxygen
easili
recruit
model
acut
lung
injuri
ali
recruit
result
oxygen
chang
consist
recruit
howev
chang
aerat
nonaer
lung
recruit
manoeuvr
adequ
repres
chang
plateau
pressur
respiratori
system
complianc
recruit
volum
seem
degre
improv
oxygen
much
determin
reduct
nonaer
lung
blood
flow
region
extracorpor
membran
oxygen
ecmo
provid
temporari
extracorpor
life
support
children
sever
respiratori
cardiac
failur
ecmo
therapi
discontinu
adequ
pulmonari
andor
cardiac
function
return
oxygen
improv
tidal
volum
increas
chest
radiograph
reveal
reduct
pulmonari
opacif
hermon
cowork
investig
whether
surfact
applic
could
influenc
variabl
children
respiratori
failur
applic
surfact
mean
tidal
volum
almost
doubl
baselin
valu
mean
complianc
increas
significantli
baselin
valu
radiograph
score
tend
decreas
within
hour
surfact
treatment
affect
mortal
help
wean
ecmo
wrigg
colleagu
demonstr
spontan
breath
airway
pressur
releas
ventil
promot
alveolar
recruit
mainli
depend
juxtadiaphragmat
lung
region
result
endexpiratori
aerat
also
led
redistribut
tidal
ventil
depend
lung
zone
oleic
acid
induc
lung
injuri
spontan
breath
airway
pressur
releas
ventil
counter
undesir
cyclic
alveolar
collaps
depend
lung
region
contribut
ventilatorassoci
lung
injuri
indic
lung
injuri
assess
data
support
hypothesi
activ
contract
diaphragm
major
explanatori
factor
improv
oxygen
observ
anim
model
patient
ali
reduct
intrapulmonari
shunt
data
suggest
allow
spontan
breath
activ
ali
could
help
reduc
lung
injuri
guttmann
repeatedli
appli
pattern
differ
level
peep
heterogen
popul
tracheal
intub
patient
unsupport
spontan
breath
level
peep
significantli
influenc
rest
shortterm
breath
pattern
select
affect
durat
expir
reduct
peep
parallel
increas
respiratori
rate
minut
ventil
paradox
tidal
volum
inspiratori
time
significantli
affect
data
suggest
exist
heringbreu
inflationdefl
reflex
adult
standard
clinic
condit
reflex
produc
increas
stretch
receptor
activ
lead
prolong
expir
bollen
cowork
report
result
multicentr
multin
trial
safeti
efficaci
highfrequ
oscillatori
ventil
hfov
ard
patient
studi
prematur
stop
poor
patient
accrual
complet
similar
trial
thirtyseven
patient
receiv
hfov
patient
receiv
convent
mechan
ventil
cmv
statist
signific
differ
mortal
surviv
without
supplement
oxygen
author
suggest
futur
trial
incorpor
oxygen
index
given
fraction
inspir
oxygen
mean
airway
pressur
arteri
carbon
dioxid
tension
inform
analysi
post
hoc
analysi
suggest
rel
improv
hfov
compar
cmv
patient
higher
baselin
oxygen
index
sleewijffel
colleagu
retrospect
singl
centr
studi
report
use
hfov
paediatr
patient
n
deterior
cmv
observ
hfov
rescu
therapi
associ
high
overal
surviv
patient
diffus
alveolar
diseas
n
surviv
rate
rate
patient
small
airway
diseas
n
futur
studi
necessari
evalu
whether
outcom
patient
diffus
alveolar
diseas
may
improv
hfov
appli
earlier
cours
lung
diseas
intrapulmonari
percuss
ventil
ipv
highfrequ
ventil
techniqu
intend
therapeut
mobil
bronchial
secret
primarili
use
patient
cystic
fibrosi
stabl
state
howev
shown
promis
increas
sputum
product
patient
chronic
obstruct
pulmonari
diseas
copd
varga
cowork
random
trial
conduct
patient
exacerb
copd
demonstr
min
ipv
led
signific
decreas
respiratori
rate
increas
arteri
oxygen
tension
decreas
arteri
carbon
dioxid
tension
p
worsen
exacerb
observ
patient
treat
ipv
compar
deterior
six
patient
control
group
p
hospit
stay
also
significantli
shorter
ipv
group
control
group
day
versu
day
p
pneumothorax
often
complic
manag
patient
sever
acut
respiratori
syndrom
sar
ventil
kao
cowork
conclud
sar
patient
suffer
pneumothorax
patient
tachypno
admiss
pronounc
hypoxaemia
hypercapnia
hospit
although
signific
differ
pressur
volum
mortal
rate
patient
without
pneumothorax
critic
ill
patient
frequent
develop
anaemia
intens
care
unit
icu
stay
partli
attribut
blunt
erythropoietin
respons
erythropoietin
endogen
glycoprotein
hormon
primari
stimulu
erythropoiesi
deangelo
colleagu
demonstr
erythropoietin
respons
also
blunt
anaem
haemoglobin
gdl
mechan
ventil
patient
compar
match
anaem
ambulatori
patient
breen
cowork
report
random
openlabel
multicentr
studi
compar
safeti
efficaci
analgesiabas
sedat
regimen
use
remifentanil
n
midazolambas
sedat
regimen
fentanyl
morphin
ad
analgesia
n
critic
ill
patient
requir
prolong
mechan
ventil
day
remifentanilbas
sedat
regimen
reduc
durat
mechan
ventil
hour
p
reduc
time
start
wean
process
extub
hour
p
prone
posit
shown
improv
arteri
oxygen
twothird
patient
ard
howev
also
increas
intraabdomin
pressur
iap
increas
iap
sever
impair
cardiopulmonari
renal
hepatosplanchn
function
short
period
prone
posit
howev
mani
patient
includ
previou
studi
place
aircushion
bed
might
impact
variabl
prospect
random
crossov
studi
michelet
cowork
compar
prone
posit
aircushion
bed
convent
foam
mattress
although
iap
significantli
higher
liver
function
decreas
convent
mattress
effect
associ
differ
oxygen
cardiovascular
paramet
mortensen
colleagu
investig
impact
empir
use
fluorquinolon
sever
pneumonia
use
report
associ
increas
mortal
wherea
combin
macrolid
improv
outcom
retrospect
analysi
elig
patient
communityacquir
pneumonia
period
mortensen
colleagu
observ
mortal
patient
treat
fluorquinolon
n
compar
rate
patient
treat
guidelineconcord
antibiot
n
adjust
confound
use
fluoroquinolon
associ
increas
mortal
odd
ratio
patient
cystic
fibrosi
aerosol
colistin
success
use
treat
acut
pulmonari
exacerb
infect
initi
colon
pseudomona
aeruginosa
strain
michalapoulo
cowork
retrospect
identifi
eight
patient
nosocomi
pneumonia
receiv
aerosol
colistin
surviv
clinic
cure
rate
infect
better
patient
pneumonia
receiv
addit
aerosol
colistin
although
find
statist
significantli
differ
patient
receiv
intraven
colistin
treatment
surviv
patient
versu
patient
p
clinic
cure
patient
versu
patient
p
number
patient
includ
small
retrospect
studi
suggest
need
random
control
trial
examin
efficaci
safeti
aerosol
colistin
manag
patient
nosocomi
pneumonia
grigoriu
colleagu
conduct
prospect
studi
mechan
ventil
patient
demonstr
cytolog
lesion
alveolar
damag
express
presenc
haemorrhag
desquam
type
ii
pneumocyt
bronchoalveolar
lavag
fluid
found
patient
sever
hospitalacquir
communityacquir
pneumonia
howev
poor
sensit
necess
train
pathologist
limit
potenti
util
approach
daytoday
practic
ventilatorassoci
tracheobronch
vat
common
nosocomi
infect
among
mechan
ventil
patient
incid
rate
report
literatur
investig
outcom
vat
retrospect
observ
match
studi
design
patient
without
chronic
respiratori
failur
nseir
colleagu
found
durat
mechan
ventil
icu
stay
prolong
patient
although
differ
mortal
although
patient
vat
treat
antibiot
treat
longer
period
match
control
individu
treat
specif
vat
analysi
adequaci
antibiot
treatment
fail
show
differ
although
result
limit
small
number
patient
receiv
adequ
treatment
garnachomontero
cowork
assess
risk
factor
clinic
featur
manag
outcom
critic
ill
patient
aspergillu
spp
isol
respiratori
secret
use
databas
patient
studi
design
assess
fungal
infect
treatment
steroid
odd
ratio
copd
odd
ratio
neutropenia
odd
ratio
significantli
associ
aspergillu
spp
isol
aspergillu
spp
recov
patient
patient
isol
aspergillu
spp
interpret
colon
mortal
patient
interpret
invas
aspergillosi
mortal
two
case
classifi
antifung
treatment
consid
patient
clinic
featur
pneumonia
isol
aspergillu
spp
respiratori
secret
either
copd
undergo
treatment
corticosteroid
contrast
antifung
treatment
initi
aspergillu
spp
recov
bronchial
aspir
critic
ill
patient
without
predispos
risk
factor
absenc
clinic
radiolog
sign
pneumonia
case
isol
aspergillu
spp
interpret
colon
sepsi
ard
cascad
inflammatori
respons
lead
product
proinflammatori
cytokin
cascad
might
inhibit
elimin
pathogen
toxin
use
haemoperfus
polymyxin
b
immobil
fibr
column
prospect
uncontrol
observ
studi
kushi
cowork
use
techniqu
patient
ard
caus
sepsi
haemoperfus
reduc
level
plasminogen
activ
neutrophil
elastas
blood
hour
improv
arteri
oxygen
tensionfract
inspir
oxygen
ratio
hour
start
treatment
sepsi
endothelin
et
releas
bloodstream
endotheli
cell
caus
local
vasoconstrict
especi
pulmonari
circul
block
receptor
decreas
extravascular
lung
water
index
endotoxaemia
kuklin
cowork
report
possibl
mechan
explain
nonselect
receptor
blocker
tezosentan
reduc
transloc
protein
kinas
c
cytosol
membran
endotoxaemia
similar
experi
conduct
experiment
anim
model
pulmonari
oedema
develop
follow
sepsi
caus
caecal
ligat
punctur
kuklin
cowork
reduc
pulmonari
oedema
block
receptor
experi
suggest
possibl
way
reduc
lung
injuri
sepsi
frank
cowork
use
oxylog
medic
best
netherland
demonstr
oscillatori
flow
potenti
harm
effect
may
occur
ventil
especi
condit
high
resist
occur
children
narrow
airway
endotrach
tube
intern
diamet
mm
sever
obstruct
lung
diseas
airway
diseas
adult
patient
oscil
present
ventil
set
must
adjust
reduc
steep
ramp
biphas
intermitt
posit
airway
pressur
assist
spontan
breath
reduc
tidal
volum
pressurelimit
intermitt
posit
pressur
ventil
partial
carbon
dioxid
rebreath
techniqu
use
estim
cardiac
output
mechan
ventil
patient
howev
carbon
dioxid
rebreath
result
increas
minut
ventil
irregular
respiratori
pattern
tachibana
cowork
report
use
shorter
durat
rebreath
versu
mitig
effect
yield
cardiac
output
measur
similar
accuraci
pulmonari
capillari
pressur
pcp
major
forc
determin
fluid
filtrat
pulmonari
capillari
interstitium
thu
major
determin
oedema
format
souza
cowork
analyz
pulmonari
arteri
pressur
decay
curv
patient
pulmonari
hypertens
due
either
idiopath
pulmonari
arteri
hypertens
ipah
n
ard
n
use
mathemat
analysi
base
fit
curv
demonstr
pcp
ipah
patient
greater
normal
differ
algorithm
yield
differ
pcp
within
group
time
need
reach
steadyst
pulmonari
arteri
occlus
pressur
longer
ipah
group
higher
time
constant
howev
methodolog
limit
occlus
techniqu
confound
interpret
differ
diseas
process
may
result
differ
time
arteri
empti
result
implic
method
avail
estim
pcp
respiratori
variat
arteri
puls
pressur
suggest
predictor
fluid
respons
mechan
ventil
patient
circulatori
failur
main
limit
method
requir
invas
arteri
cathet
cannesson
cowork
prospect
clinic
trial
mechan
ventil
patient
demonstr
strong
correl
respiratori
variat
arteri
puls
pressur
respiratori
variat
puls
oximetri
plethysmograph
waveform
amplitud
although
limit
studi
respiratori
variat
puls
oximetri
plethysmograph
waveform
amplitud
accur
discrimin
patient
respiratori
variat
system
puls
pressur
variat
less
studi
suggest
may
noninvas
approach
assess
fluid
respons
ventil
patient
wang
cowork
report
novel
approach
use
puls
oximet
monitor
left
main
bronchu
attach
doubl
lumen
tube
haemodynam
stabl
anim
well
haemorrhag
shock
suggest
techniqu
would
reliabl
oper
theatr
icu
patient
may
possibl
altern
pulmonari
arteri
cathet
certain
measur
abrahamson
cowork
describ
effect
implement
simul
protocol
sar
train
health
care
worker
manag
cardiac
arrest
wear
unfamiliar
equip
follow
modifi
advanc
cardiac
life
support
protocol
simul
provid
insight
consid
earlier
phase
develop
protocol
use
detect
correct
flaw
omiss
protocol
specif
treatment
sar
patient
insight
gain
experi
valuabl
futur
infecti
diseas
challeng
icu
needham
cowork
describ
improv
care
ali
patient
icap
studi
multisit
prospect
cohort
studi
aim
evalu
longer
term
outcom
aliard
survivor
particular
focu
effect
low
tidal
volum
ventil
critic
care
therapi
studi
enrol
consecut
mechan
ventil
aliard
patient
icu
four
hospit
citi
baltimor
maryland
usa
expect
enrol
patient
period
exposur
patient
base
clinic
manag
icu
organiz
comprehens
collect
baselin
throughout
patient
icu
stay
outcom
includ
mortal
organ
impair
function
statu
qualiti
life
assess
use
standard
survey
test
month
aliard
diagnosi
multifacet
retent
strategi
use
minim
particip
loss
follow
ali
acut
lung
injuri
ard
acut
respiratori
distress
syndrom
cmv
convent
mechan
ventil
copd
chronic
obstruct
pulmonari
diseas
ecmo
extracorpor
membran
oxygen
et
endothelin
hfov
highfrequ
oscillatori
ventil
iap
intraabdomin
pressur
icu
intens
care
unit
ipah
idiopath
pulmonari
arteri
hypertens
ipv
intrapulmonari
percuss
ventil
pcp
pulmonari
capillari
pressur
peep
posit
endexpiratori
pressur
sar
sever
acut
respiratori
syndrom
vat
ventilatorassoci
tracheobronch
receiv
consult
incom
boc
gsk
hamilton
medic
kci
maquet
ventana
also
paid
member
follow
data
safeti
monitor
board
asthmatx
broncu
leo
pharma
